Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/19/2009 | US20090286963 Antigenic fusion protein carrying gal alpha1,3gal epitopes |
11/19/2009 | US20090286958 Interferon-beta fusion proteins and uses |
11/19/2009 | US20090286861 Phenotypic reversion of pancreatic carcinoma cells |
11/19/2009 | US20090286859 POTENT LNA OLIGONUCLEOTIDES FOR THE INHIBITION OF HIF-1a EXPRESSION |
11/19/2009 | US20090286858 Assays for modulators of asparaginyl hydroxylase |
11/19/2009 | US20090286857 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders |
11/19/2009 | US20090286855 Interleukin-18 mutants, their production and use |
11/19/2009 | US20090286854 Aptamers directed to muci |
11/19/2009 | US20090286853 Modified oligonucleotides for telomerase inhibition |
11/19/2009 | US20090286852 RNA containing modified nucleosides and methods of use thereof |
11/19/2009 | US20090286851 Compositions and Methods for Delivering RNAI Using Lipoproteins |
11/19/2009 | US20090286849 Modulation of insulin like growth factor i receptor expression |
11/19/2009 | US20090286753 Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mrnas |
11/19/2009 | US20090286742 polypeptides comprising amino acid sequences corresponding to, similar to or homologous to part of the amino acid sequence of neural thread proteins, used for treating unwanted cellular proliferations such as benign prostatatic hyperplasia, cancer, unwanted facial hair, warts and fatty tissues |
11/19/2009 | US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
11/19/2009 | US20090286733 Long-acting veterinary polypeptides and methods of producing and administering same |
11/19/2009 | US20090286720 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin |
11/19/2009 | US20090286714 Novel molecules of the card-related protein family and uses thereof |
11/19/2009 | US20090286696 Double-Stranded Olidonucleotides and Uses Therefor |
11/19/2009 | US20090286687 Method and Compositions for Detection and Enumeration of Genetic Variations |
11/19/2009 | US20090286321 Methods for targeting modified raav vectors to mammalian cells |
11/19/2009 | US20090286320 Site-specific recombination in eukaryotes and constructs useful therefor |
11/19/2009 | US20090286319 Microinjection method and device |
11/19/2009 | US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
11/19/2009 | US20090286314 Fluorescent proteins and genes encoding them |
11/19/2009 | US20090286313 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties |
11/19/2009 | US20090286311 DNA sequences for the expression of alloproteins |
11/19/2009 | US20090286294 Methods and Compositions for Improving the Production of Fuels in Microorganisms |
11/19/2009 | US20090286291 Borrelidin-producing polyketide synthase and its use |
11/19/2009 | US20090286288 ALPHA-1, 4-GALACTOSYLTRANSFERASE (CgtD) FROM CAMPYLOBACTER JEJUNI |
11/19/2009 | US20090286287 METHODS AND COMPOSITIONS FOR USE IN PREPARRING siRNAs |
11/19/2009 | US20090286285 Modified Nucleic Acid Polymers and Methods for their Production |
11/19/2009 | US20090286283 Method and affinity column for purifying proteins |
11/19/2009 | US20090286282 Method for Producing Antibody Fragments |
11/19/2009 | US20090286281 Secretase for use in identifying modulator for treatment and prevention of alzheimers disease; Beta-site amyloid precursor protein cleaving enzyme (BACE) |
11/19/2009 | US20090286265 Cripto Blocking Antibodies And Uses Thereof |
11/19/2009 | US20090286262 Nucleic acid, polypeptide and its use |
11/19/2009 | US20090286259 Screening method for gpcr ligands |
11/19/2009 | US20090286254 Gene silencing |
11/19/2009 | US20090286252 Nrif3, novel co-activator for nuclear hormone receptors |
11/19/2009 | US20090286247 Novel nucleic acid base pair |
11/19/2009 | US20090286244 Fluorescent Color Markers |
11/19/2009 | US20090285968 Plants and seeds of spring canola variety scv384196 |
11/19/2009 | US20090285967 Plants and seeds of spring canola variety scv425044 |
11/19/2009 | US20090285933 Product and Process |
11/19/2009 | US20090285932 Barley lipoxygenase 1 gene, method of selecting barley variety, material of malt alcoholic drinks and process for producing malt alcoholic drink |
11/19/2009 | US20090285883 Identification of gastrointestinal, pancreatic and cancer stem cell markers and methods of use thereof |
11/19/2009 | US20090285861 Tumor cell-based cancer immunotherapeutic compositions and methods |
11/19/2009 | US20090285859 Allergenic proteins of natural rubber latex, their production and use in assays |
11/19/2009 | US20090285855 Recombinant vaccine against japanese encephalitis virus (jev) infection and a method thereof |
11/19/2009 | US20090285853 Nucleic Acids Encoding Respiratory Syncytial Virus Subgroup B strain 9320 |
11/19/2009 | US20090285852 Expression System Incorporating a Capsid Promotor Sequence as an Enhancer of a Cytomegalovirus Promotor |
11/19/2009 | US20090285848 Methods and compositions for immunizing against pseudomonas infection |
11/19/2009 | US20090285844 Non-toxic mutants of pathogenic gram-negative bacteria |
11/19/2009 | US20090285843 Epitope sequences |
11/19/2009 | US20090285825 Novel snake toxin |
11/19/2009 | US20090285824 immunoglobulins; humanizing; chimera; fragments; complementary determining regions; breast cancer |
11/19/2009 | US20090285822 Prevention and treatment of amyloidogenic disease |
11/19/2009 | US20090285821 Campylobacter Pilus Protein, Compositions and Methods |
11/19/2009 | US20090285818 Cripto Blocking Antibodies and Uses Thereof |
11/19/2009 | US20090285817 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
11/19/2009 | US20090285816 Albumin Fusion Proteins |
11/19/2009 | US20090285815 Immunoconjugates comprising cd4 and immunoglobin molecules for the treatment of hiv infection |
11/19/2009 | US20090285814 CD 40 Binding Molecules and CTL Pepetides for Treating Tumors |
11/19/2009 | US20090285809 Prevention and treatment of amyloidogenic diseases |
11/19/2009 | US20090285807 Anti-Met Monoclonal Antibody, Fragments and Vectors Thereof, for the Treatment of Tumors and Corresponding Products |
11/19/2009 | US20090285806 Methods and compositions for improving recombinant protein production |
11/19/2009 | US20090285805 Binding molecules |
11/19/2009 | US20090285803 ANTI-PirB ANTIBODIES |
11/19/2009 | US20090285801 Calcium-Sensing Receptor 2 (CaR2) and Methods for Using |
11/19/2009 | US20090285799 Antibody Antagonists of Interleukin-13 Receptor Alpha1 |
11/19/2009 | US20090285796 Mutant jak3 kinase in human leukemia |
11/19/2009 | US20090285788 RANDOM RNAi LIBRARIES, METHODS OF GENERATING SAME, AND SCREENING METHODS UTILIZING SAME |
11/19/2009 | US20090285783 Methods and compositions for cancer therapy using a novel adenovirus |
11/19/2009 | US20090285771 Methods and compositions for needleless delivery of macromolecules |
11/19/2009 | US20090285754 Peptides for targeting apoptotic cells and uses thereof |
11/19/2009 | US20090285753 Novel haptotactic peptides |
11/19/2009 | US20090285750 Agent, composition and method |
11/19/2009 | DE102008029669A1 Neue Therapeutika für die Hepatitis-Therapie New therapeutics for the treatment of hepatitis |
11/19/2009 | DE102008023447A1 New polypeptide having an amino acid position against the amino acid sequence, useful as human- or veterinary medicine and as disinfectant, and in food and cosmetics |
11/19/2009 | CA2760041A1 Methods and compositions for the treatment of cancer |
11/19/2009 | CA2725477A1 Methods for assessing colorectal cancer and compositions for use therein |
11/19/2009 | CA2725468A1 Novel bacillus thuringiensis gene with lepidopteran activity |
11/19/2009 | CA2724632A1 Asthma susceptibility loci located at chromosome 1q31 for use in diagnostic and therapeutic methods |
11/19/2009 | CA2724596A1 Self-inactivating helper adenoviruses for the production of high-capacity recombinant adenoviruses |
11/19/2009 | CA2724475A1 Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type i diabetes |
11/19/2009 | CA2724343A1 Methods and reagents for detecting cpg methylation with a methyl cpg binding protein (mbp) |
11/19/2009 | CA2724304A1 Improved yeast strain for production of four carbon alcohols |
11/19/2009 | CA2724250A1 Chimeric compositions and methods for regulating plant gene expression |
11/19/2009 | CA2724220A1 Microanalysis chip adhesive sheet, microanalysis chip, and manufacturing method thereof |
11/19/2009 | CA2724198A1 Novel and powerful mhc-class ii petptides derived from survivin |
11/19/2009 | CA2724179A1 Oligonucleotides for treating inflammation and neoplastic cell proliferation |
11/19/2009 | CA2724105A1 Diblock copolymers and polynucleotide complexes thereof for delivery into cells |
11/19/2009 | CA2724076A1 Heterologous expression of fungal cellobiohydrolases in yeast |
11/19/2009 | CA2724052A1 Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion |
11/19/2009 | CA2724014A1 Micellic assemblies |
11/19/2009 | CA2723968A1 Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means |
11/19/2009 | CA2723726A1 Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences |
11/19/2009 | CA2723595A1 Electroporation of adherent cells with an array of closely spaced electrodes |
11/19/2009 | CA2723242A1 Gene synthesis by convergent assembly of oligonucleotide subsets |